Scarica l'app Stockscreener
8.15
8.96%
-0.89
Precedente Chiudi:
$9.04
Aprire:
$8.7
Volume 24 ore:
1.97M
Relative Volume:
2.19
Capitalizzazione di mercato:
$440.11M
Reddito:
-
Utile/perdita netta:
$-86.60M
Rapporto P/E:
-2.8774
EPS:
-2.8324
Flusso di cassa netto:
$-67.37M
1 W Prestazione:
-18.35%
1M Prestazione:
+24.32%
6M Prestazione:
+77.37%
1 anno Prestazione:
-0.12%
Intervallo 1D:
$8.15
$9.0399
Intervallo di 1 settimana:
$8.23
$10.38
Portata 52W:
$1.45
$11.72
Lexeo Therapeutics Inc Stock (LXEO) Company Profile
Nome
Lexeo Therapeutics Inc
Settore
Industria
Telefono
(212) 547-9879
Indirizzo
345 PARK AVENUE SOUTH, NEW YORK
Confronta LXEO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LXEO
Lexeo Therapeutics Inc
|
8.15 | 650.61M | 0 | -86.60M | -67.37M | -2.8324 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.59 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
635.38 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
426.00 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
841.97 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
185.13 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Lexeo Therapeutics Inc Stock (LXEO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-15 | Iniziato | Guggenheim | Buy |
| 2025-07-31 | Iniziato | Oppenheimer | Outperform |
| 2024-06-13 | Iniziato | Robert W. Baird | Outperform |
| 2024-06-06 | Iniziato | H.C. Wainwright | Buy |
| 2023-11-28 | Iniziato | Chardan Capital Markets | Buy |
| 2023-11-28 | Iniziato | JP Morgan | Overweight |
| 2023-11-28 | Iniziato | Leerink Partners | Outperform |
| 2023-11-28 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-11-28 | Iniziato | Stifel | Buy |
Mostra tutto
Lexeo Therapeutics Inc Borsa (LXEO) Ultime notizie
Using data models to predict Lexeo Therapeutics Inc. stock movementJuly 2025 Momentum & Low Drawdown Momentum Ideas - newser.com
Using Python tools to backtest Lexeo Therapeutics Inc. strategiesQuarterly Earnings Report & Weekly Watchlist for Hot Stocks - newser.com
What to do if you’re stuck in Lexeo Therapeutics Inc.Market Risk Analysis & Weekly Watchlist of Top Performers - newser.com
Long term hold vs stop loss in Lexeo Therapeutics Inc.Gap Down & AI Driven Stock Reports - newser.com
How Lexeo Therapeutics Inc. stock reacts to bond yieldsEarnings Miss & Smart Allocation Stock Reports - newser.com
Can Lexeo Therapeutics Inc. stock withstand economic slowdown2025 Top Gainers & Verified Short-Term Trading Plans - newser.com
Using Ichimoku Cloud for Lexeo Therapeutics Inc. technicalsPortfolio Value Report & Real-Time Market Trend Scan - newser.com
Multi asset correlation models including Lexeo Therapeutics Inc.July 2025 Levels & Real-Time Chart Breakout Alerts - newser.com
Is Lexeo Therapeutics (LXEO) One of Billionaire Daniel Sundheim’s Stock Picks with Huge Upside Potential - Yahoo! Finance Canada
Is Lexeo Therapeutics Inc. meeting your algorithmic filter criteriaAnalyst Upgrade & Safe Investment Capital Preservation Plans - newser.com
Will Lexeo Therapeutics Inc. price bounce be sustainableTrade Volume Summary & Verified Technical Trade Signals - newser.com
Using data filters to optimize entry into Lexeo Therapeutics Inc.Portfolio Return Summary & Verified Momentum Stock Ideas - newser.com
Will Lexeo Therapeutics Inc. stock outperform Nasdaq index2025 EndofYear Setup & Safe Capital Allocation Plans - newser.com
Should you hold or exit Lexeo Therapeutics Inc. nowWeekly Volume Report & Risk Managed Investment Strategies - newser.com
Why hedge funds are buying Lexeo Therapeutics Inc. stockEarnings Beat & High Conviction Buy Zone Picks - newser.com
Best data tools to analyze Lexeo Therapeutics Inc. stockGap Down & Weekly Return Optimization Plans - newser.com
Real time pattern detection on Lexeo Therapeutics Inc. stock2025 Growth vs Value & Fast Gain Stock Trading Tips - newser.com
Can Lexeo Therapeutics Inc. stock double in next 5 yearsJuly 2025 Opening Moves & Risk Controlled Swing Trade Alerts - newser.com
RA CAPITAL MANAGEMENT, L.P. Acquires 5 Million Shares in Lexeo T - GuruFocus
RA CAPITAL MANAGEMENT, L.P. Acquires 5 Million Shares in Lexeo Therapeutics Inc - GuruFocus
Risk vs reward if holding onto Lexeo Therapeutics Inc.Market Activity Recap & Real-Time Stock Entry Alerts - newser.com
Lexeo Therapeutics (LXEO) Price Target Increased by 19.77% to 21.29 - Nasdaq
Lexeo Therapeutics Inc Azioni (LXEO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Lexeo Therapeutics Inc Azioni (LXEO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Robertson Jenny | Chief Legal Officer |
Oct 17 '25 |
Sale |
8.94 |
3,526 |
31,530 |
68,930 |
| Otero Jose Manuel | Chief Technical Officer |
Oct 17 '25 |
Sale |
8.94 |
2,115 |
18,913 |
64,197 |
| Adler Eric | Chief Medical Officer |
Oct 17 '25 |
Sale |
8.94 |
3,382 |
30,242 |
73,261 |
| Townsend Richard Nolan | Chief Executive Officer |
Oct 17 '25 |
Sale |
8.94 |
13,133 |
117,436 |
242,118 |
1.96%
0.43%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):